Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Expression of activated signal transducer and activator of transcription-3 as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma

Fig. 2

Kaplan–Meier curves showing median progress free survival (mPFS) for 153 metastasis esophageal cancer patients treated with paclitaxel and cisplatin according to p-STAT3 levels. The median PFS for patients with positive expression of p-STAT3 and negative expression of p-STAT3 was 5.0 months and 6.9 months, respectively (HR 1.380, 95 % CI 0.698 to 2.062, p < 0.001)

Back to article page